If you want to strengthen your income portfolio in March with some new additions, then it could be looking at the ASX 200 dividend stocks listed below that brokers rate as buys.
Here's what analysts are forecasting from them:
NIB Holdings Limited (ASX: NHF)
Analysts at Goldman Sachs think that this health insurance company could be an ASX 200 dividend stock to buy.
The broker likes NIB as it "offers defensive exposure to the private health insurance sector which is experiencing favourable operating trend."
It also highlights its "preference for NHF in this space reflecting strong underlying top line growth through policyholder growth and premium rate increases, greater diversity of earnings outside of regulated resident health insurance and valuation appeal."
Goldman expects this to underpin fully franked dividends per share of 31 cents in FY 2024 and 30 cents in FY 2025. Based on the current NIB share price of $7.35, this will mean 4.2% and 4.1%, respectively.
The broker currently has a buy rating and $8.10 price target on its shares.
Transurban Group (ASX: TCL)
Over at Citi, its analysts are bullish on Transurban and see it as an ASX 200 dividend stock to buy.
Transurban is the toll road operator behind roads including CityLink, Cros City Tunnel, AirportlinkM7, and the East Distributor.
Citi is positive on the company and believes it is well-positioned to pay a dividend ahead of guidance in FY 2024.
The broker recently stated its belief that "TCL's FY24 DPS guidance of 62c is conservative." This is because of "strong toll price growth, traffic growth on new road completions and a slower increase in debt costs."
Citi is forecasting dividends per share of 63.6 cents in FY 2024 and then 65.1 cents in FY 2025. Based on the current Transurban share price of $13.43, this will mean yields of 4.7% and 4.8%, respectively.
The broker currently has a buy rating and $15.60 price target on its shares.
